Skip to main content
    C

    Catalyst Pharmaceuticals Inc (CPRX)

    Official site

    BIOTECHNOLOGY

    $31.49
    +0.00 (+0.00%)

    Last updated: Jul 16, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(29/38)
    Avg Surprise
    +19.15%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$0.74
    Range$0.74 - $0.74
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.68+9.0%
    60d ago$0.68+9.0%
    30d ago$0.69+6.3%
    7d ago$0.69+6.3%
    Current$0.74
    Revenue Consensus
    $155M
    Range$152M - $158M
    4 analysts
    Period ending Sep 30, 2026
    EPS Consensus$0.82
    Range$0.82 - $0.82
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.72+14.4%
    60d ago$0.72+14.4%
    30d ago$0.73+12.1%
    7d ago$0.73+12.1%
    Current$0.82
    Revenue Consensus
    $162M
    Range$158M - $165M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.98---
    Sep 26EST
    		-$0.82---
    Jun 26EST
    		-$0.74---
    Mar 26
    Reported May 11
    		$0.79$0.64+23.44%Beat+75.6%
    Dec 25
    Reported Feb 25
    		$0.68$0.30+128.19%Beat+54.5%
    Sep 25
    Reported Nov 5
    		$0.64$0.48+33.33%Beat+12.3%
    Jun 25
    Reported Aug 6
    		$0.68$0.54+25.93%Beat+21.4%
    Mar 25
    Reported May 7
    		$0.45$0.34+32.35%Beat+18.4%
    Dec 24
    Reported Feb 26
    		$0.44$0.32+37.50%Beat+41.9%
    Sep 24
    Reported Nov 6
    		$0.57$0.51+11.76%Beat+296.6%
    Jun 24
    Reported Aug 7
    		$0.56$0.43+30.23%Beat+69.7%
    Mar 24
    Reported May 8
    		$0.38$0.30+26.67%Beat+46.2%
    Dec 23
    Reported Feb 28
    		$0.31$0.27+14.81%Beat+40.9%
    Sep 23
    Reported Nov 8
    		$-0.29$0.45-164.44%Miss-220.8%
    Jun 23
    Reported Aug 9
    		$0.33$0.41-19.51%Miss+65.0%
    Mar 23
    Reported May 10
    		$0.26$0.31-16.13%Miss+116.7%
    Dec 22
    Reported Mar 15
    		$0.22$0.21+4.76%Beat+144.4%
    Sep 22
    Reported Nov 9
    		$0.24$0.19+26.32%Beat+140.0%
    Jun 22
    Reported Aug 9
    		$0.20$0.17+17.65%Beat+81.8%
    Mar 22
    Reported May 10
    		$0.12$0.14-14.29%Miss+71.4%
    Dec 21
    Reported Mar 16
    		$0.09$0.12-25.00%Miss-18.2%
    Sep 21
    Reported Nov 9
    		$0.10$0.12-16.67%Miss-16.7%
    Jun 21
    Reported Aug 9
    		$0.11$0.10+10.00%Beat+22.2%
    Mar 21
    Reported May 10
    		$0.07$0.09-22.22%Miss-30.0%
    Dec 20
    Reported Mar 15
    		$0.11$0.09+22.22%Beat+37.5%
    Sep 20
    Reported Nov 9
    		$0.12$0.10+20.00%Beat-7.7%
    Jun 20
    Reported Aug 10
    		$0.09$0.09+0.00%Beat-10.0%
    Mar 20
    Reported May 11
    		$0.10$0.09+11.11%Beat+1100.0%
    Dec 19
    Reported Mar 16
    		$0.08$0.10-20.00%Miss+157.1%
    Sep 19
    Reported Nov 12
    		$0.13$0.12+8.33%Beat+262.5%
    Jun 19
    Reported Aug 7
    		$0.10$0.02+400.00%Beat+266.7%
    Mar 19
    Reported May 13
    		$-0.01N/A+92.31%Beat+83.3%
    Dec 18
    Reported Mar 18
    		$-0.14$-0.11-27.27%Miss-133.3%
    Sep 18
    Reported Nov 7
    		$-0.08$-0.08+0.00%Beat-60.0%
    Jun 18
    Reported Aug 7
    		$-0.06$-0.07+14.29%Beat-20.0%
    Mar 18
    Reported May 9
    		$-0.06$-0.06+0.00%Beat+0.0%
    Dec 17
    Reported Mar 14
    		$-0.06$-0.06+0.00%Beat-20.0%
    Sep 17
    Reported Nov 8
    		$-0.05$-0.06+16.67%Beat-
    Jun 17
    Reported Aug 9
    		$-0.05$-0.06+16.67%Beat-
    Mar 17
    Reported May 10
    		$-0.06$-0.06+0.00%Beat-
    Dec 16
    Reported Mar 15
    		$-0.05$-0.07+28.57%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$31.48
    SMA 20$31.45
    SMA 50$31.31
    SMA 200$25.47
    EMA 10$31.47
    EMA 20$31.42
    EMA 50$30.61
    EMA 200$26.70

    MACD

    Line: 0.14Signal: 0.19Hist: -0.05

    ADX

    ADX: 68.4+DI: 35.1-DI: 5.7

    Aroon & PSAR

    Aroon Up92.0
    Aroon DownN/A
    PSAR$31.47

    Bollinger Bands

    Upper Band$31.53
    Lower Band$31.37
    %B Position51%(Middle)
    Band Width0.74

    RSI (14-Day)

    Overbought
    70.2

    Momentum Oscillators

    Stoch %K85.6
    Stoch %D84.9
    Williams %R-15.8
    ROC (10d)0.2%
    Momentum0.05
    CCI (20d)83.0
    MFI (14d)68.4

    Volatility Measures

    ATR (14d)$0.07(0.2%)
    StdDev (20d)0.04
    Hist Vol1.4%(Low)

    Volume Flow

    VWAP$31.49
    OBV64.9M
    AD Line-16.9M
    CMF (20d)-0.063

    Volume Metrics

    Avg Vol (20d)2.6M
    Vol RatioN/A
    VWMA (20d)$31.46

    Pivot Points

    R3$31.49
    R2$31.49
    R1$31.49
    Pivot Point$31.49
    S1$31.49
    S2$31.49
    S3$31.49

    Advanced Oscillators

    TSI41.31
    Ultimate Osc40.7
    KST5.29

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$149.39M$152.61M$148.39M$146.56M$141.42M$141.82M$128.69M$122.71M$98.51M$110.57M$102.69M$99.58M
    Cost of Revenue$14.47M$26.07M$22.65M$20.61M$17.91M$21.64M$19.28M$15.40M$12.52M$15.81M$14.17M$12.04M
    Gross Profit$134.91M$126.54M$125.74M$125.95M$123.51M$120.18M$109.42M$107.31M$85.99M$94.76M$88.52M$87.54M
    Operating Expenses$61.68M$64.69M$59.47M$59.65M$60.14M$57.33M$58.51M$53.06M$58.86M$53.07M$125.71M$40.84M
    R&D$2.66M$1.81M$2.66M$4.36M$3.89M$3.80M$3.28M$2.98M$2.58M$1.97M$83.66M$3.95M
    SG&A$49.32M$53.42M$47.47M$45.95M$46.91M$44.19M$45.88M$40.73M$46.94M$42.04M$33.56M$28.40M
    Operating Income$73.23M$61.85M$66.27M$66.30M$63.37M$62.84M$50.91M$54.25M$27.13M$41.69M$-37,188,000$46.70M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$833,000$0
    Income Before Tax$84.23M$71.90M$71.03M$69.29M$71.29M$74.18M$57.20M$55.79M$29.09M$46.71M$-38,021,000$48.51M
    Income Tax Expense$20.50M$19.20M$18.25M$17.18M$14.55M$18.25M$13.32M$14.99M$5.81M$11.86M$-7,257,000$10.75M
    Net Income$63.73M$52.70M$52.78M$52.11M$56.74M$55.94M$43.88M$40.79M$23.27M$34.84M$-30,764,000$37.76M
    EBITDA$94.00M$81.44M$80.45M$78.75M$80.75M$83.64M$66.66M$65.22M$38.52M$55.85M$-29,453,000$57.08M
    EBIT$84.23M$71.90M$71.03M$69.29M$71.29M$74.18M$57.20M$55.79M$29.09M$46.71M$-38,021,000$48.51M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CPRX

    News

    Enterprise value to EBITDA forward of Catalyst Pharmaceuticals, Inc. – LS:A0LCUL

    This article displays the Enterprise Value to EBITDA forward for Catalyst Pharmaceuticals, Inc. (A0LCUL) on Lang & Schwarz Tradecenter. The page shows the current market status as closed with no trades recorded. It also...

    TradingView•7/30/26•Neutral

    Catalyst Pharmaceuticals Inc (CPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Catalyst Pharmaceuticals Inc (CPRX), noting its current earnings forecast score of 6.67...

    TradingKey•7/29/26•Neutral

    Catalyst Pharmaceuticals Inc (CPRX) Income Statement

    This article provides a detailed income statement for Catalyst Pharmaceuticals Inc (CPRX), presenting quarterly and annual financial data spanning several fiscal years. It includes key financial metrics such as total...

    TradingKey•7/26/26•Somewhat-Bullish

    Catalyst Pharmaceuticals Inc (CPRX) Cash Flow

    This article provides a detailed cash flow statement for Catalyst Pharmaceuticals Inc (CPRX), including quarterly and annual data for operating, investing...

    TradingKey•7/26/26•Neutral

    Catalyst Pharmaceuticals, Inc. Revenue Breakdown – LS:A0LCUL

    The article provides a revenue breakdown for Catalyst Pharmaceuticals, Inc. (A0LCUL). Last year, the company generated 501.32 million EUR...

    TradingView•7/26/26•Somewhat-Bullish

    CPRX Competitors

    CompanyTicker
    Edgewise Therapeutics IncEWTX
    Tango Therapeutics IncTNGX
    Indivior PLC Ordinary SharesINDV
    Envista Holdings CorpNVST
    Adaptive Biotechnologies CorpADPT
    Telix Pharmaceuticals LimitedTLX
    Premier IncPINC
    National HealthCare CorporationNHC

    Sector: Healthcare

    CPRX Bull Case vs Bear Case

    Bull case

    • CPRX beat EPS estimates in 100.0% of its last 8 reported quarters.

    CPRX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    40.3%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $0.74
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About CPRX

    Does CPRX pay dividends?

    Catalyst Pharmaceuticals Inc (CPRX) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In